Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2018-06-18
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Demonstration that the Brain Gauge can objectively measure concussion in this population and thus improve concussion identification and coding.
2. Demonstration of stronger screening for and tracking of acute concussion and documentation of concussion diagnoses, including improved tracking of recovery and greater adherence to DOD/VA Clinical Practice Guidelines for acute concussion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tele-Rehabilitation to Improve Mild Traumatic Brain Injury Recovery and Reduce Subsequent Injury Risk
NCT05594225
The Study of Cognitive Rehabilitation Effectiveness for Mild Traumatic Brain Injury
NCT01339806
Telephone Follow-Up on Outcome After Mild Traumatic Brain Injury
NCT00483444
"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"
NCT01248390
Acute Concussion Therapy Intervention Training in Healthy and Concussed Participants
NCT02872480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A retrospective cohort of 300 anonymized patients from Landstuhl Regional Medical Center will be used as historical controls to assess diagnosis and recovery patterns, while a comparison cohort of 100 healthy active duty members from Fort Bragg, NC, will be used as uninjured controls to establish baseline Brain Gauge metrics in this population.
For the prospective cohort, all participants will receive comprehensive standard of care medical assessment and treatment as determined by their clinical team and as appropriate to their injury and course of recovery. In addition to standard assessments, participants will complete the Brain Gauge assessments at home or in the clinic at selected time points from initial assessment through 90 days post-study entry. The Brain Gauge system is designed for use by the patient at home and is easily incorporated in a remote, tele-health based patient monitoring system.
Data will be analyzed for compliance with current military Clinical Practice Guidelines (CPGs) for mTBI, both with the use of the Brain Gauge system and prior to its implementation. Objective cortical neurofunctional measures from the Brain Gauge instrument will be compared to standardized clinical measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospective
retrospective review of 300 records of patients following concussive diagnosis to track recovery and adherence to progressive return to activity recommendations.
No interventions assigned to this group
Prospective
300 prospective patients enrolled following concussive diagnosis to track recovery, clinical diagnosis and brain gauge performance.
Brain Gauge Prospective and Healthy Control
The Brain Gauge is a brain health assessment system that takes advantage of the well-documented relationship between the sensory nerves in the fingers and the projection of those nerves to corresponding regions in the brain. The system is composed of a test device (the Brain Gauge) that uses novel fingertip vibration patterns to probe cortical complexity and utilize that complexity to gain more sensitive and specific detection of compromised neural function.
Control Group
75-100 Healthy Controls recruited by Fort Bragg to assess performance in a healthy population for brain gauge performance.
Brain Gauge Prospective and Healthy Control
The Brain Gauge is a brain health assessment system that takes advantage of the well-documented relationship between the sensory nerves in the fingers and the projection of those nerves to corresponding regions in the brain. The system is composed of a test device (the Brain Gauge) that uses novel fingertip vibration patterns to probe cortical complexity and utilize that complexity to gain more sensitive and specific detection of compromised neural function.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brain Gauge Prospective and Healthy Control
The Brain Gauge is a brain health assessment system that takes advantage of the well-documented relationship between the sensory nerves in the fingers and the projection of those nerves to corresponding regions in the brain. The system is composed of a test device (the Brain Gauge) that uses novel fingertip vibration patterns to probe cortical complexity and utilize that complexity to gain more sensitive and specific detection of compromised neural function.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed concussion within the last 72 hours
Exclusion Criteria
* Subtest test records incomplete for key variables such as symptom report inventories.
* Current MEB in process.
* Pregnant women as there are parts of the Clinical practice guide that cannot be implemented as a part of standard clinical care due to pregnancy.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Defense and Veterans Brain Injury Center
FED
Kendra Jorgensen-Wagers
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kendra Jorgensen-Wagers
Senior Clinical Research Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kendra L Jorgensen-Wagers, Ph.D
Role: PRINCIPAL_INVESTIGATOR
The Defense and Veterans Brain Injury Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Landstuhl Regional Medical Center
Landstuhl, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N00014-18-C-2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.